FOR IMMEDIATE RELEASE

 

 

NEW INTERNATIONAL TRANSPORT REGULATIONS TO RESHAPE CLINICAL TRIAL PRACTICES

 

STAMFORD, Connecticut, December 10, 2003—An expert panel of speakers representing the transportation industry, pharmaceutical practitioners, and international health and regulatory bodies briefed 250 of the world’s foremost clinical trial researchers on impending regulatory changes that will affect the packaging and shipping of diagnostic and infectious substances at World Courier’s recent International Transportation Bioseminar held in Basel, Switzerland.

 

Moderator for the one-day event was Mr. Sergio Benassai, Chairman of the U.N. Subcommittee of Experts on the Transport of Dangerous Goods. Mr. Benassai was joined at the podium by:

 

§         Mr. Jean Abouchaar, Director, Cargo, Regulatory & Industry Affairs for IATA

§         Dr. Nicoletta Previsani, World Health Organization

§         Ms. Judith Code, Chairman of ICAO’s Dangerous Goods Panel

§         Dr. Didier Guilhem, Senior Research Scientist, Aventis Pharma

§         Mr. Maxence Wittebolle, General Manager, Belgian Packing Institute

§         Mr. Remy A. Rodas, Esq., Curtis, Mallet-Prevost, Colt & Mosle LLP

§         Dr. Melanie Saville, Director of Virology, Wyeth Vaccine Research

§         Dr. Mikhail Samsonov, Medical Director, Central and Eastern Europe for Bristol Myers Squibb

§         Mr. Michael T. Sweeney, Director of Development & Compliance for World Courier Inc.

 

“As clinical trials are undertaken in increasingly diverse locations worldwide, it is imperative that the regulations governing the transportation of biological specimens – particularly infectious substances – be continuously revised, clarified and communicated,” says Wayne B. Heyland, President and Chief Executive Officer of World Courier Group. “Classifications must be objective and unambiguous, and handling procedures must be strictly controlled, documented and enforced.”

 

“Ensuring international compliance with changing regulations is a huge challenge since today’s global study will typically involve a variety of organizations in a variety of industries operating in many different countries. Our international bioseminars are instrumental in bringing together professionals from all sides to discuss these important issues and determine how universal compliance can be best realized,” explains Mr. Heyland. “Without far-reaching compliance, the transportation of biological specimens becomes more costly and complicated.”

 

To date, World Courier has hosted eight of these high-level seminars: Brussels, Belgium (1996 and 1998); London, U.K. (1998); Buenos Aires, Argentina (1999); Sydney, Australia (2000); Miami, Florida (2001); Singapore, Singapore (2002); and Basel, Switzerland (2003).

 

The specific regulatory changes that will come into effect January 1, 2005 relate to the four former Risk Group classifications which will give way to three new designations: Category A (highly infectious, including Risk Group IV substances and cultures), Category B (all other diagnostic specimens and those containing Risk Group II and III pathogens), and “Not Regulated” (blood/tissue/organs etc., collected for transfusion/transplant).

 

“If risk is to be minimized, if people are to be protected, and if clinical trials are to come in on time and on budget, it is critical that all parties associated with the transportation of biological substances – from the regulatory agencies overseeing transportation practices to the lab personnel, couriers and airline staff who actually handle the shipments – become fully familiar with and adhere to the proper packing and shipping practices,” says Mr. Heyland.

 

Incorporated in 1969, World Courier has set the benchmark for worldwide time-sensitive transportation. It remains the only specialist courier company with its own global network dedicated to treating every shipment on an individual, priority basis. Today, World Courier is the acknowledged leader in delivering customized solutions and value-added services in growth markets such as the bio-medical, automotive and high-tech industries. Headquartered in Stamford, Connecticut, World Courier maintains a comprehensive international network of over 130 wholly-owned offices operating in 48 countries around the globe.

 

 

 – 30 –

 

 

Contacts

 

North America

Dennis Tselentis

Executive Vice President, Marketing and Sales

World Courier Inc.

1313 - 4th Avenue

New Hyde Park, NY, 11040

Telephone: (516) 354-2600

Toll-free: 1-800-231-7227

Fax: (516) 354-2713

E-mail: dtselentis@worldcourier.com

 

Europe, Middle East & Africa

Noël Foucart

Director, Sales and Marketing

World Courier Belgium N.V.

6 A Hermesstraat

B-1930 Zaventem

Belgium

Telephone: 32/2/712-5080

Fax: 32/2/712-5089

E-mail: nfoucart@worldcourier.be

 

Latin America

Carlos Jankowski

Regional Director, Latin America

World Courier Argentina S.A.

Avda. Corrientes 316 D, Piso 7

Buenos Aires, Argentina

Telephone: 54/1/4328-8300

Fax: 54/1/4328-5879

E-mail: jankowski@worldcourier.com.ar

Asia Pacific

Korhan Yalcinyuva

Regional Director, Asia Pacific

World Courier (Australia) Pty. Ltd.

Unit 1, 8 Lord Street

Botany N.S.W. 2019

Australia

Telephone: 61/2/8335 9100

Fax: 61/2/8335 9170

E-mail: kyalcinyuva@worldcourier.com.au